Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial

Marc‐Oliver Grimm, Emilio Esteban, Philippe Barthélémy, Manuela Schmidinger, Jonas Busch, Begoña P. Valderrama, Natalie Charnley, Marc Schmitz, Ulrike Schumacher, Katharina Leucht,

The Lancet Oncology · 2023 · 34 citations · 16 references

Concepts

References

16